Waters Corporation (WAT) Revenue by Segment & Business Profile
Waters Analytical And Materials Sciences was 45.9% of Waters Corporation's revenue across the 3 lines it reports, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-07-04 · read by EquiReason
WATWaters CorporationFollow WAT — free
—
Price chart with a free account
- Market cap
- 44.6B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
What the company does
Waters Corporation is a diagnostics & research company in the healthcare sector. In its SEC filings it reports 3 business lines: Waters Analytical And Materials Sciences (46%), Waters Advanced Diagnostics (32%), Waters Biosciences (22%). Trailing twelve-month revenue: $4.6 billion as of 2026-07-04.
Roles we read
from the filings, not the sector label- Life-science tools
- Clinical diagnostics
Revenue by geography
latest quarter · company segment note| Region | Revenue | Share | y/y |
|---|---|---|---|
| United States | 570M | 34.6% | +148.9% |
| European Union | 505M | 30.7% | +124.4% |
| Asia Other | 244M | 14.8% | +63.8% |
| China | 206M | 12.5% | +76.1% |
| Americas Other | 120M | 7.3% | +135.3% |
Waters Corporation — questions
- What does Waters Corporation do?
- Waters Corporation is a diagnostics & research company in the healthcare sector. In its SEC filings it reports 3 business lines: Waters Analytical And Materials Sciences (46%), Waters Advanced Diagnostics (32%), Waters Biosciences (22%). Trailing twelve-month revenue: $4.6 billion as of 2026-07-04.
- How does Waters Corporation make money?
- By the lines it reports in its SEC filings: Waters Analytical And Materials Sciences 45.9%, Waters Advanced Diagnostics 31.7%, Waters Biosciences 22.4% of revenue.
Every figure on this page comes from Waters Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.